Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority study of emergence time after short- versus long-duration remimazolam anesthesia
jRCT1011260046Recruiting
- Sponsor
- Sapporo Medical University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam (2 arms), sponsored by Sapporo Medical University. Primary endpoint: Time from discontinuation of remimazolam to eye opening in response to verbal stimulation. Started Sep 2026; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT1011260046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011260046.